Perfectionism as a predictor of change in digital self-guided interventions for public speaking anxiety in adolescents: A secondary analysis of a four-armed randomized controlled trial.
Smiti KahlonRolf GjestadPhilip LindnerTine NordgreenPublished in: Cognitive behaviour therapy (2023)
Public Speaking Anxiety (PSA) interventions targeting adolescents exist; however, not all gain improvement. This exploratory study investigated whether PSA interventions resulted in a decrease in perfectionism and whether pre-treatment level and changes in perfectionism moderated the effects on PSA and social anxiety. The sample consisted of 100 adolescents from junior high schools randomized to four groups: 1) VR only ( n = 20), 2) VR + online exposure program ( n = 20), 3) online psychoeducation and online exposure program ( n = 40), 4) waitlist and online psychoeducation program ( n = 20). Self-reported symptoms of PSA, social anxiety, and perfectionism were measured at pre, week 3, post, and 3-months follow-up. Level and change in outcome variables were analyzed using latent growth curve modeling. Results revealed that the interventions did not lead to a reduction in perfectionism. Reduction in perfectionism was associated with a larger reduction in all outcome measures from post to follow-up. No interaction was found between pre-treatment perfectionism and PSA symptoms. High pre-treatment levels of perfectionism were associated with poorer outcomes on social anxiety symptoms from post to follow-up for online exposure groups. The results indicate that one should assess and address high pre-treatment levels of perfectionism during PSA interventions.
Keyphrases
- prostate cancer
- physical activity
- healthcare
- randomized controlled trial
- sleep quality
- social media
- young adults
- mental health
- health information
- radical prostatectomy
- quality improvement
- clinical trial
- type diabetes
- systematic review
- mass spectrometry
- insulin resistance
- single cell
- depressive symptoms
- weight loss
- phase ii
- double blind
- electronic health record
- drug delivery
- phase iii